20
Participants
Start Date
September 1, 2023
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2026
Oral Ultramicronized-Palmitoylethanolamide (um-PEA; 600 mg per day) in tablet form
Um-PEA is to be taken orally once a day (600 mg per day) around mealtime during the 12-week initial phase of the study. During the 24-week extension phase of the study, the trial medication is to be taken from once a day up to twice a day (600-1200 mg per day), based on clinical judgment of the improvement obtained so far, around mealtime.
RECRUITING
Unit of Psychiatry, University Hospital of Udine, Udine
University of Udine
OTHER